FIB‐4 Index and APRI Score Predict Short‐ and Long‐Term Mortality in Hospitalized COVID‐19 Patients: A 4‐Year Follow‐Up Study
Journal of Medical Virology · 2026
DOI: 10.1002/jmv.70964 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Halise Çınar Yavuz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Umraniye Training and Research Hospital, University of Health Sciences, Istanbul, Turkey. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Noninvasive liver fibrosis indices, including the Fibrosis‐4 (FIB‐4) and AST‐to‐platelet ratio index (APRI), are widely used in clinical practice. We investigated whether admission FIB‐4 and APRI, together with inflammatory markers and comorbidities, chest CT severity, and intensive care unit (ICU) admission, were associated with short‐ and long‐term mortality in hospitalized COVID‐19 patients. We retrospectively analyzed 691 adults hospitalized with PCR‐confirmed COVID‐19 between October and November 2020. Demographic characteristics, comorbidities, admission laboratory parameters, chest CT severity, length of stay, and intensive care unit (ICU) admission were recorded. Mortality during hospitalization, within 100 days, and within 4 years was obtained from the hospital database. FIB‐4 and APRI were calculated using routine laboratory parameters. The cohort included 410 women (59.3%) and 281 men (40.7%); 79 patients (11.4%) required ICU admission, and 36 (5.2%) had malignancy. In‐hospital, 100‐day, and 4‐year mortality rates were 12.0%, 14.6%, and 23.3%, respectively. Across all time points, mortality was associated with older age, higher inflammatory markers (including CRP), higher neutrophil counts and neutrophil‐to‐lymphocyte ratio (NLR), higher FIB‐4 and APRI scores, severe chest CT findings, ICU admission, and comorbidities including malignancy, hypertension, and chronic renal failure. Lymphocyte count, hemoglobin, and platelet count were inversely associated with mortality. Admission inflammatory markers and noninvasive fibrosis indices (FIB‐4 and APRI), combined with comorbidities and disease severity (CT and ICU requirement), are strong predictors of short‐ and long‐term mortality up to 4 years in hospitalized COVID‐19 patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Umraniye Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
ORCID-Profile: Halise Çınar Yavuz, Şerife Nur Boysan, Mazhar Müslüm Tuna
Zitieren
APA
Yavuz, H. Ç., Boysan, Ş. N., & Tuna, M. M. (2026). FIB‐4 Index and APRI Score Predict Short‐ and Long‐Term Mortality in Hospitalized COVID‐19 Patients: A 4‐Year Follow‐Up Study. Journal of Medical Virology. https://doi.org/10.1002/jmv.70964
Vancouver
Yavuz HÇ, Boysan ŞN, Tuna MM. FIB‐4 Index and APRI Score Predict Short‐ and Long‐Term Mortality in Hospitalized COVID‐19 Patients: A 4‐Year Follow‐Up Study. Journal of Medical Virology. 2026. doi:10.1002/jmv.70964
BibTeX
@article{Yavuz2026,
author = {Yavuz, Halise Çınar and Boysan, Şerife Nur and Tuna, Mazhar Müslüm},
title = {FIB‐4 Index and APRI Score Predict Short‐ and Long‐Term Mortality in Hospitalized COVID‐19 Patients: A 4‐Year Follow‐Up Study},
journal = {Journal of Medical Virology},
year = {2026},
doi = {10.1002/jmv.70964}
}
EUVIMED